The DocTalk series, where we discuss current events on the full spectrum of women’s health and family building and what they might mean for you. From news, research studies, industry updates, and everything in-between, we’re going to break it all down with the facts. Featuring Progyny’s Chief Medical Officer, Dr. Janet Choi, and host, Progyny SVP of Experience, Lissa Kline, LCSW. Reach out to us at comms@progyny.com.
Your trusted source for straight answers on all things women’s health and family building
Latest release
About the episode
Today, we’re exploring exciting new research out of The Turek Clinic on a medication you may know by Accutane. While most people recognize isotretinoin as an acne treatment, this recent study suggests it may have the power to “jump-start” sperm production in men with severe infertility. Joining us is Molly Jessup, Nurse Practitioner at The Turek Clinic, who will walk us through the research and what it could mean for men or couples navigating fertility challenges.
DocTalk Shorts
Bite-sized, data-driven clips that deliver key insights, research highlights, and expert takeaways in a format that’s easy to digest for people who want the facts without the fluff.
Women’s Health
Your spot for women’s reproductive care to maternal wellness and the conditions that uniquely impact women’s bodies.
Watch Now
Fertility & Family Building
Fast facts on support for family building, whether through IVF, egg freezing, surrogacy, or beyond.
Watch Now
Men’s Health
It’s not all about the female factor but also male fertility, sperm health, and common concerns like testosterone and aging.
Watch Now
Menopause & Midlife
Evidence-based insights on managing menopause and perimenopause + what you should expect at each stage.
Watch Now
Full Episodes
Could Accutane jump-start male fertility?
Doctor answers PCOS Reddit questions
STAR: AI meets fertility treatment
Five conditions women face more often than men
Cracking the code on male fertility
Fertility myth busting
Oprah’s Menopause Revolution
What are doulas?